Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma

Details for Australian Patent Application No. 2006259220 (hide)

Owner MannKind Corporation

Inventors Qiu, Zhiyong; Bot, Adrian

Agent Davies Collison Cave

Pub. Number AU-B-2006259220

PCT Pub. Number WO2006/138567

Priority 60/691,579 17.06.05 US

Filing date 16 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 11 October 2012

International Classifications

C12N 5/00 Undifferentiated human, animal or plant cells, e.g. cell lines

A61K 39/00 Medicinal preparations containing antigens or antibodies

C07K 14/435 Peptides having more than 20 amino acids - from animals

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/138567 Priority application(s): WO2006/138567

11 October 2012 Application Accepted

  Published as AU-B-2006259220

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259221-Multivalent entrain-and-amplify immunotherapeutics for carcinoma

2006259214-Method for making carbon powder and installation therefor